Fusion mutants of Newcastle disease virus selected with monoclonal antibodies to the hemagglutinin-neuraminidase

scientific article published on November 1, 1992

Fusion mutants of Newcastle disease virus selected with monoclonal antibodies to the hemagglutinin-neuraminidase is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JVI.66.11.6626-6633.1992
P953full work available at URLhttp://jvi.asm.org/cgi/content/abstract/66/11/6626
https://europepmc.org/articles/PMC240158
https://europepmc.org/articles/PMC240158?pdf=render
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1404607/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1404607/pdf/?tool=EBI
P932PMC publication ID240158
P698PubMed publication ID1404607

P2093author name stringR. L. Glickman
R. M. Iorio
P2860cites workNucleotide sequence of the gene encoding the Newcastle disease virus hemagglutinin-neuraminidase protein and comparisons of paramyxovirus hemagglutinin-neuraminidase protein sequencesQ45834577
Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachmentQ45847117
Receptor binding characteristics of strains of the influenza Hong Kong subtype, using a periodate sensitivity testQ46063484
Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteinsQ27860987
Prediction of protein conformationQ28240456
Parainfluenza 3 virus: plaque-type variants lacking neuraminidase activityQ36429487
Preliminary analysis of the requirements for fusion from within and fusion from without by Newcastle disease virusQ36444986
Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusionQ36680205
Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza virusesQ36691954
Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusionQ36692466
Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia.Q36699165
Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognitionQ36797868
Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies.Q36857975
Receptor-binding characteristics of monoclonal antibody-selected antigenic variants of influenza virusQ36907064
Biological consequences of neuraminidase deficiency in Newcastle disease virusQ36907624
Revertant analysis of a temperature-sensitive mutant of Newcastle disease virus with defective glycoproteins: implication of the fusion glycoprotein in cell killing and isolation of a neuraminidase-deficient hemagglutinating virusQ36940403
Neuraminidase activity and syncytial formation in variants of parainfluenza 3 virusQ37107939
Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunityQ37401975
Expression at the cell surface of biologically active fusion and hemagglutinin/neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA.Q37536794
Selection of unique antigenic variants of Newcastle disease virus with neutralizing monoclonal antibodies and anti-immunoglobulinQ37552898
Syncytium formation by recombinant vaccinia viruses carrying bovine parainfluenza 3 virus envelope protein genesQ40116691
The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses.Q40286662
A single amino acid substitution in the hemagglutinin-neuraminidase of Newcastle disease virus results in a protein deficient in both functionsQ41609490
Expression of mumps virus glycoproteins in mammalian cells from cloned cDNAs: both F and HN proteins are required for cell fusionQ41631732
Intracellular processing, glycosylation, and cell-surface expression of the measles virus fusion protein (F) encoded by a recombinant adenovirusQ41741539
Identification of amino acid residues important to the neuraminidase activity of the HN glycoprotein of Newcastle disease virusQ43715676
Reducing agent-sensitive dimerization of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus correlates with the presence of cysteine at residue 123.Q44072721
A fusing mumps virus variant selected from a nonfusing parent with the neuraminidase inhibitor 2-deoxy-2,3-dehydro-N-acetylneuraminic acidQ44079237
The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusionQ44586115
Identification of amino acids involved in the sialidase activity of the mumps virus hemagglutinin-neuraminadase proteinQ44788104
Nucleotide sequence of the envelope protein genes of a highly virulent, neurotropic strain of Newcastle disease virusQ44861717
Newcastle disease virus evolution. I. Multiple lineages defined by sequence variability of the hemagglutinin-neuraminidase geneQ45138708
Monoclonal antibodies as functional probes of the HN glycoprotein of Newcastle disease virus: antigenic separation of the hemagglutinating and neuraminidase sitesQ45795624
Conversion of nonfusing mumps virus infections to fusing infections by selective proteolysis of the HN glycoproteinQ45796040
Differences in bovine parainfluenza 3 virus variants studied by sequencing of the genes of viral envelope proteinsQ45807909
Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virusQ45818684
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectNewcastle diseaseQ11903425
Newcastle disease virusQ327082
P304page(s)6626-6633
P577publication date1992-11-01
P1433published inJournal of VirologyQ1251128
P1476titleFusion mutants of Newcastle disease virus selected with monoclonal antibodies to the hemagglutinin-neuraminidase
P478volume66